CereVasc
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
$85MSeries C
Role not disclosedM
Medtronic
Activity from announced rounds
Activity in this selectionSeries C+
Medtronic is the healthcare-technology company identified as a strategic investor in Cornerstone and CereVasc announcements.
Recorded funding activity
Cornerstone develops surgical robots. CereVasc develops minimally invasive hydrocephalus treatment, while Pulnovo develops interventions for pulmonary hypertension and heart failure. These are distinct medical-device businesses within the recorded corporate activity.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $85M 1 disclosed · full round size, not this investor’s share